Advertisement
Screener

VolitionRx Limited (VNRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

VolitionRx Limited Cash Flow Breakdown

Cash flow breakdown shows where VolitionRx Limited's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $19.68M went out.
  • Fiscal year ended 2025-12-31: from investing, $89.56K went out.
  • Fiscal year ended 2025-12-31: from financing, $17.09M came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.15M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$19.68M-$89.56K-$877.55K$1.98M-$210.03K$11.17M$5.03M*-$2.15M
2024-12-31-$25.89M-$573.85K$0.00-$1.09M$1.37M-$139.94K$8.59M-$17.47M
2023-12-31-$18.06M-$1.08M-$31.77K-$981.29K$1.85M-$203.88K$28.39M$9.86M
2022-12-31-$15.28M-$1.57M$0.00-$1.27M$1.52M-$180.47K$6.74M-$9.71M
2021-12-31-$20.85M-$973.56K-$130.43K$23.22M$1.14M
2020-12-31-$16.46M-$1.65M-$187.47K$21.20M$2.48M
2019-12-31-$12.74M-$511.27K$16.59M$3.54M
2018-12-31-$14.73M-$301.81K$436.78K*$1.16M$17.25M$3.31M
2017-12-31-$12.19M-$1.43M$1.20M$998.41K-$11.56M
2016-12-31-$8.86M-$415.09K$25.30M$15.76M
2015-12-31-$8.55M-$132.19K$12.50M$3.78M
2014-12-31-$4.14M-$302.99K$5.63M$1.25M
2013-12-31-$3.08M-$714.00$2.83M$765.18K*$512.28K
2012-12-31-$2.31M-$90.69K$2.58M$28.53K
2011-12-31-$1.65M-$34.87K$1.60M$300.41K

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$5.16M*-$1.79K*-$180.42K*$0.00*-$125.00*$5.44M*
2026-03-31-$5.28M-$9.21K-$246.19K$962.72K-$15.71K$5.17M$1.74M*$1.99M
2025-12-31-$5.49M*-$10.97K*-$180.38K*$410.00K*-$50.19K*$6.72M*
2025-09-30-$3.63M*$0.00*-$285.35K*$0.00*-$80.38K*$2.01M*
2025-06-30-$6.26M*-$76.78K*-$160.06K*$0.00*-$55.06K*$62.56K*$5.82M*
2025-03-31-$4.30M-$1.81K-$251.76K$1.57M-$24.41K$2.38M-$664.09K
2024-12-31-$5.43M*-$197.86K*$0.00*-$256.01K*$614.04K*-$82.81K*$2.03M*
2024-09-30-$5.39M*-$136.74K*$0.00*-$300.81K*$0.00*-$15.86K*$5.96M*
2024-06-30-$6.73M*-$160.45K*$0.00*-$320.55K*$754.46K*-$38.20K*$589.49K*
2024-03-31-$8.34M-$78.81K$0.00-$210.18K$0.00-$3.06K$15.73K-$8.96M
2023-12-31$6.45M*-$308.72K*$0.00*-$300.97K*$1.64M*-$123.65K*$2.59M*
2023-09-30-$8.42M*-$273.04K*$0.00*-$204.36K*$0.00*$0.00*-$85.57K*
2023-06-30-$7.35M*-$301.39K*$0.00*-$252.63K*-$65.89K*$17.45M*
2023-03-31-$8.74M-$200.59K-$31.77K-$223.34K-$14.34K$8.43M-$856.17K
2022-12-31-$5.80M*-$578.75K*$0.00*-$326.53K*-$30.20K*$781.79K*
2022-09-30-$6.82M*-$325.49K*$0.00*-$310.19K*-$82.29K*$5.95M*$1.17M*
2022-06-30-$6.27M*-$541.29K*$0.00*-$380.96K*-$67.99K*-$3.00*
2022-03-31$3.61M-$124.65K$0.00-$250.71K$0.00$9.47K$3.15M
2021-12-31-$4.41M*-$128.57K*$1.78M*
2021-09-30-$4.88M*-$141.81K*$252.93K*
2021-06-30-$5.40M*-$219.24K*$854.71K*
2021-03-31-$6.17M-$483.94K$20.33M$13.62M
2020-12-31-$2.73M*-$1.07M*$2.00M*
2020-09-30-$4.50M*$14.97K*$4.97M*
2020-06-30-$4.43M*-$266.68K*$118.29K*$14.23M*
2020-03-31-$4.80M-$330.69K$0.00
2019-12-31-$2.60M*-$151.76K*$88.35K*$102.82K*-$2.73M*
2019-09-30-$3.72M*-$122.67K*$115.24K*$4.83M*$1.19M*
2019-06-30-$2.77M*-$124.73K*$59.84K*$5.00M*$2.34M*
2019-03-31-$3.65M-$112.10K$87.58K$6.66M$2.74M
2018-12-31-$3.63M*-$118.26K*$66.87K*$449.35K*-$2.95M*
2018-09-30-$4.61M*-$58.03K*$9.00M*$4.48M*
2018-06-30-$2.98M*-$64.86K*-$296.93K*$1.00*$797.51K*-$2.37M*
2018-03-31-$3.51M-$60.66K-$35.93K$7.80M$4.14M
2017-12-31-$3.89M*-$84.98K*$1.00*-$3.72M*
2017-09-30-$2.82M*-$105.34K*$119.00K*-$2.66M*
2017-06-30-$2.81M*-$360.00K*$836.11K*-$1.97M*
2017-03-31-$2.67M-$874.89K$43.30K-$3.21M
2016-12-31-$2.19M*-$325.66K*$11.80M*$9.15M*
2016-09-30-$2.11M*-$21.05K*$192.50K*-$1.97M*
2016-06-30-$2.40M*$56.77K*-$2.51M*
2016-03-31-$2.16M$13.26M$11.09M
2015-12-31-$2.07M*-$9.31K*$1.16M*-$935.52K*
2015-09-30-$2.34M*-$5.64K*$0.00*$82.50K*-$2.46M*
2015-06-30-$1.93M*-$43.95K*$50.00K*-$1.72M*
2015-03-31-$2.21M-$73.30K$11.20M$8.89M
2014-12-31-$992.67K*-$5.38K*$733.42K*-$280.70K*
2014-09-30-$863.60K*-$250.94K*$1.77M*$611.40K*
2014-06-30-$1.31M*-$28.60K*$352.50K*-$992.53K*
2014-03-31-$977.56K-$18.07K$2.77M$1.91M
2013-12-31-$709.27K*-$1.00*$956.75K*$415.23K*
2013-09-30-$827.84K*$1.00*$450.00K*-$277.27K*
2013-06-30-$990.75K*$0.00*$825.50K*$517.28K*$339.88K*
2013-03-31-$556.35K-$714.00$596.00K$34.45K
2012-12-31-$447.29K*-$19.11K*$624.75K*$61.14K*
2012-09-30-$723.53K*-$455.00*$664.25K*-$70.97K*
2012-06-30-$579.67K*-$33.33K*$808.13K*$168.44K*
2012-03-31-$564.08K-$37.80K$479.25K-$130.08K
2011-12-31-$573.53K*-$10.34K*-$1.00*-$611.20K*
2011-09-30-$445.15K*-$20.26K*$1.25M*$686.70K*
2011-06-30-$295.49K*-$4.26K*$111.91K*-$292.74K*
2011-03-31-$338.27K$0.00$230.00K$617.75K*$517.65K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92